Drugs / Ombitasvir/paritaprevir/ritonavir
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03549832 Comparator | Jan 2018 → Jan 2019 | hepatitis C virus infection | Assiut University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ombitasvir/paritaprevir/ritonavir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03549832 ↗ |
| Route | Oral | “Ombitasvir/paritaprevir/ritonavir oral pills” NCT03549832 ↗ |